DENTAL-BIO™
Microbiome-oriented oral care platform.
- Product family
- 3 complementary formats
- Planned market availability
- Q4 2026
- Seeking
- Distribution Partners

Our portfolio includes commercial products, commercialization preparation, planned launches and selected pharmaceutical, ophthalmology and MedTech development programmes. Public 2026–2027 timelines reflect plans subject to confirmation.
Alongside its pharmaceutical and medical technology pipeline, ACS Biomed is developing differentiated healthcare platforms whose formulations and positioning have already been defined and which are entering the next phase of sampling, industrialization and commercial development.
Microbiome-oriented oral care platform.

A next-generation oral-gel platform under development combining water-free formulation technology, mucoadhesive delivery and microbiome-focused functional components.
Women’s vitality platform segmented by life stage.

Specialist system for women’s intimate wellbeing.

Functional topical platform for everyday mobility and comfort.

Multi-active platform for men’s vitality across different life stages.
